We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VistaGen Therapeutics Inc | NASDAQ:VTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 3.17% | 4.55 | 3.98 | 9.39 | 4.55 | 4.31 | 4.47 | 191,064 | 05:00:08 |
Nevada
|
000-54014
|
20-5093315
|
(State or other jurisdiction of
incorporation) |
(Commission File Number)
|
(IRS Employer
Identification Number) |
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
VTGN
|
Nasdaq Capital Market
|
Exhibit No.
|
Description
|
|
Press Release issued by Vistagen Therapeutics, Inc., dated February 7, 2023.
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
Vistagen Therapeutics, Inc.
|
||
|
|
|
Date: February 7, 2023
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn K. Singh
Chief Executive Officer
|
1 Year VistaGen Therapeutics Chart |
1 Month VistaGen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions